Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 18 (9) , 576-589.e1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of Hodgkin Lymphoma: A 50-Year PerspectiveJournal of Clinical Oncology, 2014
- Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort StudyJournal of Clinical Oncology, 2011
- Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation VolumesJournal of Clinical Oncology, 2009
- Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's LymphomaJournal of Clinical Oncology, 2007
- High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupJournal of Clinical Oncology, 2003
- Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsBlood, 2002
- Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 YearsJournal of Clinical Oncology, 2002
- Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young AdulthoodJournal of Clinical Oncology, 2000
- Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at TreatmentJournal of Clinical Oncology, 2000
- Second cancer risk following Hodgkin's disease: a 20-year follow-up study.Journal of Clinical Oncology, 1994